FDA warns of fake Ozempic in US drug supply chain
The FDA issued an advisory warning about counterfeit Ozempic shots in the drug supply chain. The agency has seized thousands of units of the counterfeit product and is investigating the occurrences of fake semaglutide. The FDA advised wholesalers, pharmacies, healthcare practitioners, and patients to check their products and not use those labeled with specific serial numbers. The agency found that needles in the counterfeit samples are fake and pose an increased risk of infection. Only five adverse events have been reported so far. The FDA recommends purchasing the drug through authorized distributors.
Source: Link
Frequently Asked Questions
Counterfeit Ozempic Warning
What is Ozempic (semaglutide), and what is it used for?
Ozempic (semaglutide) is a medication marketed for the treatment of Type 2 diabetes and may also be prescribed for weight loss. It is administered through injection using a pen.
Why did the FDA issue a warning about counterfeit Ozempic?
The FDA has found counterfeit Ozempic injections in the legitimate U.S. drug supply chain and is currently investigating the situation to ensure patient safety.
How can consumers identify counterfeit Ozempic products?
Details about distinguishing counterfeit products have not been specified in the provided links. However, consumers are generally advised to be vigilant about the packaging, check the pen label, and consult with pharmacists or healthcare providers if they suspect they have a counterfeit product.
What components of the Ozempic medication have been confirmed as counterfeit?
Confirmed counterfeit components include the pen label and the accompanying information leaflet.
What should I do if I suspect I have a counterfeit Ozempic product?
If you suspect that you have a counterfeit Ozempic product, you should contact your healthcare provider for guidance and report the issue to the FDA.
Has any information about the quality or safety of the counterfeit drugs been released?
As of the last update provided, the quality, safety, and exact identity of the counterfeit drugs are not yet available. The FDA is still investigating these aspects.
Who is working with the FDA to address the issue of counterfeit Ozempic?
Novo Nordisk, the manufacturer of Ozempic, is collaborating with the FDA to address and alert the public about the counterfeit drug issue.
Is there any advice for pharmacists regarding counterfeit Ozempic?
Pharmacists are encouraged to vet their suppliers carefully and report any suspicions of counterfeit products to the FDA.
Is counterfeit medication a common problem in the U.S.?
It is relatively rare for counterfeit medications to make it past pharmacists and into the U.S. drug supply; however, cases like this highlight the importance of vigilance in the supply chain.
For specific details pertaining to FOX 31 Denver's coverage or additional questions not covered here, please visit the article directly on their website or check the other provided links for more information.